Inventor · disambiguated record
Kevin De Braganca
Also filed as: DE BRAGANCA KEVIN · DE BRAGANCA KEVIN C
0 granted patents·3 pending applications·0 citations·filing 2021–2025
Top patents by PatentIndex Score
3 records- 0152US2023061503A1Methods of minimizing neurotoxicity associated with chimeric antigen receptor (car) t cell therapyJANSSEN BIOTECH INC·Filed 2022·Application pending·0 cites
- 0245US2021330254A1Neurologic toxicity assessement methods and systems for documenting changes in handwritingJANSSEN BIOTECH INC·Filed 2021·Application pending·0 cites
- 0333US2025269024A1Bcma-targeted car-t cell therapy for multiple myelomaLEGEND BIOTECH USA INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin De Braganca files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →